The endocannabinoid system (ECS) is a vital biological network found in all mammals, playing a key role in regulating several physiological processes such as memory, sleep, immune responses, and more.

The ECS is composed of two main types of cannabinoid receptors, CB1 and CB2. These receptors interact with endocannabinoids, which are naturally produced in the body, as well as plant-derived cannabinoids, triggering a variety of responses throughout the body.

Research suggests that cannabinoids may offer various therapeutic benefits, including antioxidant, neuroprotective, anti-inflammatory, pain-relieving, anti-tumor, sleep-regulating, anti-psychotic, and anti-anxiety effects.

Among cannabinoids, delta-9-tetrahydrocannabinol (THC) is the most recognized for its psychoactive effects, influencing mood, perception, cognition, and motor skills. On the other hand, cannabidiol (CBD), a non-psychoactive cannabinoid, has gained attention for its medicinal properties without inducing a “high.”